Article Details

Landos Biopharma, Inc. (NASDAQ:LABP) Receives Consensus Rating of “Hold” from Analysts

Retrieved on: 2022-10-01 10:04:34

Tags for this article:

Click the tags to see associated articles and topics

Landos Biopharma, Inc. (NASDAQ:LABP) Receives Consensus Rating of “Hold” from Analysts. View article details on HISWAI: https://www.etfdailynews.com/2022/10/01/landos-biopharma-inc-nasdaqlabp-receives-consensus-rating-of-hold-from-analysts/

Excerpt

Read Landos Biopharma, Inc. (NASDAQ:LABP) Receives Consensus Rating of “Hold” from Analysts at ETF Daily News.

Article found on: www.etfdailynews.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up